STOCK TITAN

Vanguard Capital Management (CME) reports 27.0M shares, 7.45% ownership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

CME Group Inc ownership filing: Vanguard Capital Management reports beneficial ownership of 27,044,709 shares of Common Stock, equal to 7.45% of the class as reported for the period ending 03/31/2026.

The filing states Vanguard has sole dispositive power over 27,044,709 shares and sole voting power for 3,677,427 shares. The filing describes holdings held on behalf of various Vanguard affiliates and funds. Signature on the filing is dated 04/29/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard holds a sizeable passive stake of 7.45% in CME Group as of 03/31/2026.

Vanguard Capital Management reports beneficial ownership of 27,044,709 shares with sole dispositive authority and limited sole voting power. The disclosure identifies multiple Vanguard affiliates and indicates these shares include fund and managed-account holdings.

Implications depend on trading decisions by underlying funds and affiliates; cash‑flow treatment and any planned transactions are not stated in the excerpt.

Beneficial ownership 27,044,709 shares reported as of 03/31/2026
Percent of class 7.45% percent of Common Stock reported
Sole voting power 3,677,427 shares shares for which Vanguard has sole voting power
Sole dispositive power 27,044,709 shares shares for which Vanguard has sole dispositive power
Filing signature date 04/29/2026 signature certifying Schedule 13G
Schedule 13G regulatory
"Name of form: SCHEDULE 13G reporting beneficial ownership"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficially owned financial
"reflects the securities beneficially owned, or deemed to be beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 27044709"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.





12572Q105

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.


SCHEDULE 13G



Vanguard Capital Management
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:04/29/2026

FAQ

How many CME (CME) shares does Vanguard Capital Management report owning?

Vanguard reports beneficial ownership of 27,044,709 shares (7.45%). The Schedule 13G lists this amount and percent as of the reporting period ending 03/31/2026 and shows sole dispositive power for that full share count.

Does Vanguard have voting control over all the CME shares it owns?

No; Vanguard reports sole voting power for 3,677,427 shares. The filing shows sole dispositive power over 27,044,709 shares but only sole voting power for a smaller subset of those shares.

Are Vanguard's CME holdings held on behalf of other Vanguard affiliates or funds?

Yes; the filing states holdings include shares held by Vanguard funds and affiliates. The Schedule 13G names Vanguard Asset Management Limited and other Vanguard divisions as entities through which dispositive power is exercised.

What date does the ownership percentage refer to in the filing?

The reported stake of 7.45% is tied to the period ending 03/31/2026. The form header lists that date and the signature on the filing is dated 04/29/2026, which certifies the disclosure.

Does the Schedule 13G disclose any planned sales or purchases by Vanguard in CME stock?

No planned transactions are disclosed in the excerpt. The Schedule 13G reports beneficial ownership and voting/dispositive powers but does not state any intended purchases or dispositions.